Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple home device replace overnight lab tests for sleep apnea?

NCT ID NCT07530302

Diagnosis Sponsor: University Hospital, Grenoble Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a small, single-use home monitor called Sunrise can help doctors decide how to adjust CPAP therapy for people with obstructive sleep apnea who are not getting enough benefit. About 105 adults will use the Sunrise device at home and also undergo a standard overnight lab test. The goal is to see if the home device leads to the same treatment decisions as the lab test, potentially making care more convenient and accessible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sunrise device (mandibular movement-based sleep monitor)
What this could lead to
If successful, this could allow people with sleep apnea to have their CPAP therapy adjusted at home instead of spending a night in a sleep lab.
What could go wrong
This is a small, early-stage trial (105 people) comparing a new device to the gold standard. The device may not be accurate enough, and results may not apply to everyone with sleep apnea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 105 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 85 years * Patients treated with Resmed CPAP * Residual apnea-hypopnea index under CPAP (rAHI(CPAP) \> 10 events/hour) * Access to a smartphone and home internet connection, and ability to use a mobile application * Signed informed consent * Affiliated with, or beneficiary of, a national health insurance program Exclusion Criteria: * Severe chronic obstructive or restrictive pulmonary disease, with or without supplemental oxygen * Unstable cardiovascular disease or severe heart failure requiring hospitalization within the past 3 months, or meeting New York Heart Association (NYHA) class III or IV criteria * Conditions affecting mandibular condyle rotation or temporomandibular joint function * Refusal to shave excessive facial hair when required for proper placement of the Sunrise device * Participation in another interventional clinical study or currently within an exclusion period of another study * Individuals who, in the investigator's judgment, are unlikely to comply with study procedures or requirements * Individuals who cannot be contacted in case of emergency * Persons protected under French Public Health Code articles L1121-5, L1121-6, and L1121-8 (including pregnant or breastfeeding women, persons deprived of liberty, individuals under psychiatric care under articles L.3212-1 or L.3213-1, individuals admitted to healthcare or social institutions for reasons other than research, and persons under legal protection or unable to provide informed consent) * Staff members with a hierarchical relationship to the principal investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep apnea syndrome, obstructive are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep apnea syndrome, obstructive

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Grenoble Alpes

    RECRUITING

    Grenoble, 38043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.